Author:
WU YAN,ZHAO GUANG,LI HENGJIN,ZHENG ZHIZHONG,ZHONG SHAOMIN,YANG ZHIYONG,FENG ZHENG,YANG QINPING,ZHU XUEJUN
Publisher
Ovid Technologies (Wolters Kluwer Health)
Subject
Dermatology,General Medicine,Surgery
Reference16 articles.
1. A multicenter, double-blind, randomized, placebo-controlled study of the efficacy and safety of botulinum toxin type A in the treatment of glabellar lines.;Carruthers;J Am Acad Dermatol,2002
2. Treatment of glabellar frown lines with C botulinum A exotoxin.;Carruthers;J Dermatol Surg Oncol,1992
3. Botulinum toxin for the correction of hyperkinetic facial lines.;Goodman;Australas J Dermatol,1998
4. Botulinum toxin A for hyperkinetic facial lines: results of a double-blind, placebo-controlled study.;Keen;Plast Reconstr Surg,1994
5. A double-blind, randomized, placebo-controlled, two-dose comparative study of botulinum toxin type a for treating glabellar lines in Japanese subjects.;Harii;Aesthetic Plast Surg,2008
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Botulinum toxins: Racial/ethnic considerations and expert techniques for optimal outcomes;Cosmetic Procedures in Skin of Color;2025
2. DaxibotulinumtoxinA for injection to treat moderate or severe glabellar lines: a randomized, multicenter, Phase III, double-blind, placebo-controlled trial in China;Journal of Plastic, Reconstructive & Aesthetic Surgery;2024-09
3. Anatomy, Etiology, Management, and Medico-Legal Implications of Botulinum-induced Blepharoptosis;Current Reviews in Clinical and Experimental Pharmacology;2024-08-16
4. Neuromodulators in Skin of Color: An International Review;Dermatologic Surgery;2024-07-09
5. A multicenter, double-blind, randomized, parallel-group, active-controlled, phase 3 clinical trial to compare the effectiveness and safety of two botulinum toxin type A formulations for improving moderate to severe glabellar wrinkles in Asians;Journal of Dermatological Treatment;2024-06-16